Amphastar Pharmaceuticals, Inc. Other Non-Current Liabilities
Amphastar Pharmaceuticals, Inc. (AMPH) had Other Non-Current Liabilities of $29.44 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Liabilities, Noncurrent $29.44M.
- 2026-03-31: Other Liabilities, Noncurrent $29.36M.
- 2025-12-31: Other Liabilities, Noncurrent $29.98M.
- 2025-09-30: Other Liabilities, Noncurrent $29.27M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $29.44M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $29.36M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $29.98M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $29.27M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $27.80M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $24.42M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $20.95M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $27.04M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $18.80M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $17.98M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $22.72M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $15.70M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $17.63M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $15.18M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $14.56M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $14.19M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $15.33M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $15.49M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $15.65M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $14.88M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $13.48M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $13.42M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $13.21M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $11.35M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $11.00M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $10.26M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $9.43M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $8.98M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $9.03M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $8.86M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $8.94M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $7.96M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $7.63M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $8.13M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $7.06M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $1.97M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.87M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.77M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $3.21M 10-K · filed 2018-03-14 | $1.77M 10-K · filed 2017-03-15 |
| 2016-09-30 | $1.97M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $2.02M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $2.13M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.91M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $631.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $757.00K 10-Q · filed 2015-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |